Kelly L. Covert

ORCID: 0000-0003-1262-9423
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmacological Effects and Toxicity Studies
  • Antimicrobial Resistance in Staphylococcus
  • Pharmaceutical Practices and Patient Outcomes
  • Venous Thromboembolism Diagnosis and Management
  • Renal Transplantation Outcomes and Treatments
  • Antibiotics Pharmacokinetics and Efficacy
  • Medication Adherence and Compliance
  • Bacterial Identification and Susceptibility Testing
  • Antibiotic Resistance in Bacteria
  • Urinary Tract Infections Management
  • Clostridium difficile and Clostridium perfringens research
  • Autoimmune and Inflammatory Disorders Research
  • Immune Cell Function and Interaction
  • Atrial Fibrillation Management and Outcomes
  • Blood Coagulation and Thrombosis Mechanisms
  • Infective Endocarditis Diagnosis and Management
  • Monoclonal and Polyclonal Antibodies Research
  • Urinary Bladder and Prostate Research
  • Genetics and Neurodevelopmental Disorders
  • Acute Kidney Injury Research
  • Neurological Complications and Syndromes
  • Biosimilars and Bioanalytical Methods
  • Health Literacy and Information Accessibility
  • Innovations in Medical Education
  • Polyomavirus and related diseases

East Tennessee State University
2016-2025

Merck (Germany)
2022

Medical University of South Carolina
2016-2017

In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon possible after acceptance. Accepted have been peer-reviewed and copyedited, but are posted before technical formatting author proofing. These not final version record will be replaced with article (formatted per style proofed by authors) at a later time. The purpose this study was assess incidence sodium-glucose cotransporter 2 (SGLT2) inhibitor initiation in hospitalized patients heart failure...

10.1093/ajhp/zxaf025 article EN American Journal of Health-System Pharmacy 2025-02-04

A lack of research exploring post-transplant process optimization to reduce readmissions and increasing readmission rates at our center from 2009 2013 led this study, aimed assessing the effect patient factors on 30-d after kidney transplantation. This was a retrospective case-control study in adult transplant recipients. Univariate multivariate analyses were utilized assess determinants readmissions. 384 patients included; significantly associated with graft loss death (p = 0.001). Diabetes...

10.1111/ctr.12748 article EN Clinical Transplantation 2016-04-21

Study Objective Drug‐related problems (DRPs) are associated with increased rates of infection, rejection, and graft loss in kidney transplant recipients. This study aimed to develop a model predict which patients at highest risk DRPs streamline pharmacists’ workflow chronic clinic. Design Prospective observational study. Setting Chronic clinic large, tertiary care, academic hospital. Patients Two hundred thirty‐seven adults seen the between September 16, 2015, November 30, who were least 90...

10.1002/phar.1886 article EN Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2016-12-20

Study Objective Induction immunosuppression significantly improves graft outcomes after kidney transplantation, but protocols vary among transplant centers due to the lack of data identifying an optimal induction agent. The objective this study was assess effectiveness evidence-based protocol change in therapy adult recipients. Design Retrospective cohort study. Setting Large tertiary care academic medical center. Patients A total 349 patients transplanted between August 2011 and December...

10.1002/phar.1941 article EN Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2017-05-05

Abstract Introduction To improve comprehension of medical care, the Joint Commission recommends that patient education materials (PEMS) be written at a fifth‐grade reading level or below. Objectives The purpose this study was to evaluate compliance commonly used tertiary drug references standards. Methods PEMs for top 100 most prescribed medications in 2017 were obtained from information (Lexi‐comp information, Micromedex Care Notes, Med Essential Fact Sheets, Medline Plus, and Drugs.com)...

10.1002/jac5.1321 article EN JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2020-09-21

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and largely viewed as an illness involving multiple organ systems. In the wake of illness, many survivors fully recover return to baseline, while others suffer from a wide range lingering symptoms collectively known "post-COVID conditions". The recognition these conditions clinical entity represents first step in developing targeted plan for recovery symptom mitigation. While...

10.1002/jac5.1655 article EN JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2022-05-26

Staphylococcus aureus bacteremia represents significant burden on the healthcare system with early mortality rates as high 60% and more recent studies suggesting of 10–30% (1,2). While methicillin-resistant (MRSA) has garnered much attention due to higher treatment difficulties, optimal methicillin-susceptible (MSSA) is still in question (1).

10.21037/aoi.2018.10.01 article EN Annals of Infection 2018-01-01

The objective of this study was to measure virtually-based structured clinical exam (OSCE) pass rates student pharmacists who received remote, synchronous instruction on medication reconciliation compared with OSCE from the previous class, face and OSCEs. secondary perceptions remote preparation.

10.59942/2325-9981.1122 article EN International Journal of Health Sciences Education 2021-07-30
Coming Soon ...